FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent
Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.
June 18, 2025
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.
The availability of a generic version likely means a lower cost of PrEP.
Youth can now benefit from the HIV prevention treatment.
The Food and Drug Administration on Wednesday approved Atripla, a combination pill containing three anti-HIV drugs that's taken just once daily. The pill will be the simplest antiretroviral regimen ever available in the United States.
